Cytomedix Inc (NASDAQOTCBB:CMXI)

CAPS Rating: 1 out of 5

A biotechnology company that develops and licenses autologous cellular therapies, including Cytomedix's proprietary AutoloGel(tm) Process to produce a platelet rich plasma gel for the treatment of wounds.

Recs

0
Player Avatar Momentum21 (98.07) Submitted: 8/15/2012 4:22:19 PM : Underperform Start Price: $1.10 CMXI Score: +6.67

what a terrible entry point CAPS gave me here. who cares though...I will make it work!

Featured Broker Partners


Advertisement